Similar articles

• Retraction: Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2.

  Sugawara S, Muramoto K. Sugawara S, et al. J Immunol. 2010 Apr 1;184(7):4042. doi: 10.4049/jimmunol.1090011. J Immunol. 2010. PMID: 20304833 No abstract available.
• Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.

  Sallenave JM, Shulmann J, Crossley J, Jordana M, Gauldie J. Sallenave JM, et al. Am J Respir Cell Mol Biol. 1994 Dec;11(6):733-41. doi: 10.1165/ajrcmb.11.6.7946401. Am J Respir Cell Mol Biol. 1994. PMID: 7946401
• Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells.

  Shpacovitch VM, Brzoska T, Buddenkotte J, Stroh C, Sommerhoff CP, Ansel JC, Schulze-Osthoff K, Bunnett NW, Luger TA, Steinhoff M. Shpacovitch VM, et al. J Invest Dermatol. 2002 Feb;118(2):380-5. doi: 10.1046/j.0022-202x.2001.01658.x. J Invest Dermatol. 2002. PMID: 11841560
• Cytokine binding and clearance properties of proteinase-activated alpha 2-macroglobulins.

  LaMarre J, Wollenberg GK, Gonias SL, Hayes MA. LaMarre J, et al. Lab Invest. 1991 Jul;65(1):3-14. Lab Invest. 1991. PMID: 1712874 Review.
• Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener's granulomatosis.

  Csernok E, Holle JU, Gross WL. Csernok E, et al. Clin Exp Rheumatol. 2008 May-Jun;26(3 Suppl 49):S112-7. Clin Exp Rheumatol. 2008. PMID: 18799068 Review.